The distinctive mutational spectra of polyomavirus-negative merkel cell carcinoma

Cancer Research

Volumn 75, Issue 18, 2015, Pages 3720-3727

  Harms, Paul William ^a   Vats, Pankaj ^a,b   Verhaegen, Monique Elise ^a   Robinson, Dan R ^a   Wu, Yi Mi ^a   Dhanasekaran, Saravana Mohan ^a   Palanisamy, Nallasivam ^a,c   Siddiqui, Javed ^a   Cao, Xuhong ^a   Su, Fengyun ^a   Wang, Rui ^a   Xiao, Hong ^a,c   Kunju, Lakshmi P ^a   Mehra, Rohit ^a,c   Tomlins, Scott A ^a,d   Fullen, Douglas Randall ^a   Bichakjian, Christopher Keram ^a   Johnson, Timothy M ^a   Dlugosz, Andrzej Antoni ^a,e   Chinnaiyan, Arul M ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BHARATHIDASAN UNIVERSITY   (India)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; CARRIER PROTEIN; DNA; GPRIN2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; ONCOPROTEIN; PRUNE2 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; MALE; MERKEL CELL TUMOR; MIDDLE AGED; MUTATION RATE; NONHUMAN; NOTCH GENE; ONCOGENE; ONCOGENE H RAS; PIK3CA GENE; POLYOMAVIRUS; PRIORITY JOURNAL; PRUNE2 GENE; RB1 GENE; SANGER SEQUENCING; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; VALIDATION STUDY; VIRUS DETECTION; ADVERSE EFFECTS; CELL TRANSFORMATION; DNA MUTATIONAL ANALYSIS; EXOME; GENE EXPRESSION PROFILING; GENETICS; MERKEL CELL POLYOMAVIRUS; MUTATION; PAROTID GLAND TUMOR; POINT MUTATION; PROCEDURES; RADIATION INDUCED NEOPLASM; RADIATION RESPONSE; SECONDARY; SKIN TUMOR; ULTRAVIOLET RADIATION;

AGED; CARCINOMA, MERKEL CELL; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXOME; GENE EXPRESSION PROFILING; HUMANS; MALE; MEMBRANE PROTEINS; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS, FUSION; ONCOGENES; PAROTID NEOPLASMS; POINT MUTATION; RECEPTORS, NOTCH; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84942856307     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0702     Document Type: Article

References (29)

1. Erstad DJ, Cusack JCJr. Mutational analysis of merkel cell carcinoma. Cancers 2014;6:2116-36.
2. Bhatia S, Afanasiev O, Nghiem P. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep 2011;13:488-97.
3. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-100.
4. Verhaegen ME, Mangelberger D, Weick JW, Vozheiko TD, Harms PW, Nash KT, et al. Merkel cell carcinoma dependence on bcl-2 family members for survival. J Invest Dermatol 2014;134:2241-50.
5. Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med 2011;3:111ra121.
6. Cimino PJ, Robirds DH, Tripp SR, Pfeifer JD, Abel HJ, Duncavage EJ. Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma. Mod Pathol 2014;27:1073-87.
7. Graves CA, Jones A, Reynolds J, Stuart J, Pirisi L, Botrous P, et al. Neuroendocrine merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case-based study using targeted massively parallel sequencing. Neuroendocrinology 2015;101:112-9.
8. Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, et al. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 2013;133:936-45.
9. Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet 2013;45:1446-51.
10. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078-9.
11. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy-number alteration discovery in cancer by exome sequencing. Genome Res 2012;22:568-76.
12. Lonigro RJ, Grasso CS, Robinson DR, Jing X, Wu YM, Cao X, et al. Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. Neoplasia 2011;13:1019-25.
13. Kim D, Salzberg SL. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 2011;12:R72.
14. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012;7:562-78.
15. Fisher CA, Harms PW, McHugh JB, Edwards PC, Siddiqui J, Palanisamy N, et al. Small cell carcinoma in the parotid harboring Merkel cell polyomavirus. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:703-12.
16. Rodig SJ, Cheng J, Wardzala J, Do Rosario A, Scanlon JJ, Laga AC, et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012;122:4645-53.
17. Paulson KG, Lemos BD, Feng B, Jaimes N, Penas PF, Bi X, et al. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma, including amplification of L-Myc. J Invest Dermatol 2009;129:1547-55.
18. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature 2013;500:415-21.
19. Fimereli D, Gacquer D, Fumagalli D, Salgado R, Rothe F, Larsimont D, et al. No significant viral transcription detected in whole breast cancer transcriptomes. BMC Cancer 2015;15:147.
20. Rudd ML, Price JC, Fogoros S, Godwin AK, Sgroi DC, Merino MJ, et al. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res 2011;17:1331-40.
21. Lee CS, Bhaduri A, Mah A, Johnson WL, Ungewickell A, Aros CJ, et al. Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. Nat Genet 2014;46:1060-2.
22. Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012;485:502-6.
23. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012;44:1006-14.
24. Machida T, Fujita T, Ooo ML, Ohira M, Isogai E, Mihara M, et al. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene 2006;25:1931-42.
25. Prickett TD, Zerlanko BJ, Hill VK, Gartner JJ, Qutob N, Jiang J, et al. Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation. J Invest Dermatol 2014;134:2390-8.
26. Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist 2007;12:535-42.
27. Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A 2011;108:17761-6.
28. Kleiblova P, Shaltiel IA, Benada J, Sevcik J, Pechackova S, Pohlreich P, et al. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint. J Cell Biol 2013;201:511-21.
29. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333:1157-60.